A new report suggests a noninvasive means to evaluate portal hypertension in patients with BCR::ABL1-negative ...

In this randomized controlled trial of patients with pulmonary arterial hypertension (PAH) and high risk of mortality, ...

The pulmonary arterial hypertension treatment market has witnessed a significant transformation in recent years, driven by advancements in medical research and increasing awareness about rare ...

Pulmonary hypertension (PH) is a rare, progressive, debilitating condition characterised by elevated pulmonary artery ...

The FDA approved treprostinil (Yutrepia) inhalation powder for pulmonary arterial hypertension and pulmonary hypertension ...

Low-dose metformin delivered to the pulmonary arteries using lipid-based nanocapsules, safely eased signs of PAH in rats.

Like other inhaled prostaglandins, YUTREPIA may cause acute bronchospasm. Patients with asthma or chronic obstructive pulmonary disease (COPD), or other bronchial hyperreactivity, are at increased ...

Background Pulmonary hypertension (PH) is a progressive cardiopulmonary condition associated with increased morbidity and ...

In a significant step towards advancing specialized cardiopulmonary care, Kauvery Hospital, Vadapalani, inaugurated its ...

lumc.nl Learn the current definition and classification of pulmonary hypertension. Learn the role of different diagnostic techniques in pulmonary hypertension. Learn about current medical and surgical ...

Pulmonary hypertension (PH) is a hemodynamic syndrome defined as ... allows us to identify strengths and opportunities for improvement at a multi-institutional level in our country that can improve ...

Higher serum sodium levels, even within the normal range, are linked to increased risk of developing hypertension and heart ...